Duke Health leadership launched Translating Duke Health in 2017 as a multi-disciplinary, multi-year commitment to capitalize on Duke’s collective strengths in research, clinical care, and population health to address major health challenges.
Members of the Duke Neurology Department contributed to 12 new peer-reviewed journal articles published this August. Highlights include a review article examining evoked potentials used for deep brain stimulation in Parkinson’s, the healthcare received by veterans with epilepsy, the optimal stroke treatments for patients with cerebral venous thrombosis, and other topics.
Members of the Duke Neurology Department contributed to eight articles and two correspondence letters published in peer-reviewed journals this July.
U.S. News & World Report ranked Duke University Hospital as the top hospital in North Carolina and the 23rd best across the nation for neurology and neurosurgery in its 2022-2023 hospital rankings. The annual rankings, which assessed more than 4,500 hospitals nationwide, analyze and integrate dozens of medical and surgical services.
This June, members of the Duke Neurology Department contributed to 12 new peer-reviewed journal articles as well as two new book chapters. Among other findings these studies uncovered retinal differences that may one day act as early biomarkers for cognitive impairment, population-based studies that will improve treatment for stroke and other conditions, and investigations of hydrogel scaffolds as potential therapies.
This week’s Spotlight interview shines on Samantha Lowenberg, a registered nurse at our Morreene Road Clinic. Lowenberg talks to us about the joys and challenges of her work helping patients with ALS, dementia, and other conditions. She also shares her hobbies of painting, playing music, and traveling when she’s not at Duke.
Members of the Duke Neurology Department contributed to 13 new peer-reviewed journal articles this May, advancing our understanding of how viruses that kill cancer cells may be used against brain tumors, the optimal treatments for various types of stroke, the origins of Parkinson’s disease, and more. Read the paragraphs below for summaries of our research from the past 31 days, as well as links to the complete articles themselves.
The newest NIH Alzheimer’s Disease Research Center (ADRC)—a collaboration established in Fall 2021 between Duke and the University of North Carolina (UNC)—is focused on identifying age-related changes across the lifespan that impact the development, progression, and experience of Alzheimer’s disease and related dementias. The center will also identify how factors that arise in early- and mid-life contribute to racial, ethnic, and geographic disparities in dementia.
This March, members of our Department contributed to studies that reveal potential new therapeutic targets for Alzheimer’s disease, help triage patients suffering from traumatic brain injury, address issues contributing to physician burnout, and more. In all, our faculty, staff, students, and trainees contributed to 15 studies published over the past 31 days. Read about them and find links to the original articles below.
Parkinson’s and Movement Disorders
Zhiyong Liu, PhD, learned about the devastating effects neurodegenerative diseases have on patients and their families firsthand during his senior year of college, when he worked in a clinical research lab. Now, as a postdoctoral associate within the lab of Andy West, PhD, he’s performing translational research to develop new treatments for one of those conditions, Alzheimer’s disease. In this week’s “Spotlight” interview, Liu talks about the focus of his work, his recent K99/R00 award, and enjoying running, fishing, and time with his family when he’s not at work.